Cartalax (20mg)
Original price was: $79.00.$59.00Current price is: $59.00.
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
Cartalax
Lyophilized Powder | Third-Party Tested | USA-Manufactured
In Stock | Free Shipping on Orders Over $150
Product Specifications
- Peptide Name: Cartalax
- Molecular Formula: C12H19N3O8
- Molecular Weight: 333.29 g/mol
- CAS Number: 87815447
- Sequence: Ala-Glu-Asp (AED)
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Storage: -20°C (long-term) | 2–8°C (short-term) | Protect from light
- Shelf Life: Up to 12 months when stored sealed and dry
Compound Overview
Cartalax is a short synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid. Structurally, it is classified as a low-molecular-weight regulatory peptide characterized by a simple linear amino acid sequence and standard α-peptide linkages between residues.
In laboratory research contexts, Cartalax is evaluated within controlled in vitro systems for peptide identity confirmation, stability profiling, and structure–function investigations involving short regulatory peptide fragments. Analytical workflows commonly include chromatographic separation and mass spectrometry verification under validated laboratory conditions. All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for Cartalax as a research compound.
Published Preclinical Research
Published literature describes short regulatory peptide fragments such as Cartalax as defined research compounds investigated within controlled experimental systems.
- Structural characterization of short tripeptide regulatory sequences in laboratory assays
- Peptide stability and degradation profiling in controlled in vitro environments
- Comparative evaluation of low-molecular-weight peptide fragments in preclinical models
- Analytical detection and quantification using LC-MS methodologies
All data referenced on this page is derived from published preclinical animal and in vitro studies. No human clinical trials have established approved uses for Cartalax.
Research Applications
- Peptide identity confirmation in laboratory analytical workflows
- Structure–function modeling of short linear peptide fragments
- Chromatographic and mass spectrometry method development
- Comparative analysis of low-molecular-weight regulatory peptides
- Controlled in vitro peptide interaction studies
Physical Specifications
- Vial Size: 3 mL sterile vial
- Fill: 20mg
- Appearance: White to off-white lyophilized powder
- Reconstitution Volume: Researcher-determined under validated laboratory protocols
- Post-Reconstitution Storage: 2–8°C, use within 30 days
- Solubility: Water-based laboratory solvents
Compare to Related Compounds
Pinealon
- Cartalax is a linear tripeptide composed of Ala-Glu-Asp, whereas Pinealon is a short peptide fragment with a distinct amino acid sequence and structural classification.
- Analytical differentiation is based on sequence composition, molecular weight, and peptide-specific chromatographic and mass spectrometry identity signatures.
NA Epithalon Amidate
- Cartalax is a non-modified tripeptide with standard α-linkages, whereas NA Epithalon Amidate is a tetrapeptide analog with terminal modification affecting structural classification.
- These compounds are distinguished in laboratory characterization by primary sequence length, terminal modifications, and analytical detection profiles.
Handling & Storage
Lyophilized Stability:
When stored sealed in a dry environment protected from light, lyophilized peptide material may maintain chemical stability for up to 12 months at controlled room temperature. For maximum long-term preservation, storage at -20°C is recommended.
Post-Reconstitution Stability:
Following reconstitution under sterile laboratory conditions, the solution may maintain stability for up to 30 days when stored at 2–8°C. Minimize repeated freeze–thaw cycles and protect from light to preserve peptide integrity.
Handling:
Allow vial to equilibrate to room temperature before opening to prevent moisture condensation. Use sterile technique throughout preparation.
Certificate of Analysis & Third-Party Testing
Every batch of BioEdge Cartalax undergoes independent third-party testing prior to release. Testing is performed by ISO-accredited laboratories with results available on each product page.
| Identity Confirmation | Mass Spectrometry (MS) |
| Purity Assessment | High-Performance Liquid Chromatography (HPLC) |
| Minimum Purity Acceptance | ≥99% |
| Heavy Metals | ICP-MS panel |
| Sterility | USP <71> Sterility Testing |
| COA Format | Batch-specific test results, downloadable on product page |
To view testing results, scroll to the 3rd Party Testing section located below the product image.
Why Researchers Choose BioEdge for Cartalax
Batch-specific COA from an independent lab. Not a generic PDF recycled across products. Every vial of Cartalax ships with a Certificate of Analysis from an independent third-party laboratory. HPLC confirms purity. Mass spectrometry confirms molecular identity. The COA corresponds to the specific batch you receive.
USA lyophilization. Many vendors import pre-filled vials from overseas and relabel them. BioEdge sources API and performs lyophilization within the United States, maintaining direct quality control over the final product.
No filler compounds. BioEdge Cartalax is pure lyophilized peptide. No mannitol, no bulking agents, no unnecessary excipients.
Same-day shipping. Domestic orders placed before 3pm ship the same day. Free shipping on orders over $150.
Frequently Asked Questions
What is Cartalax?
Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid supplied exclusively for laboratory research use.
What is the CAS number for Cartalax?
87815447
How should Cartalax be stored?
Store sealed in a dry environment protected from light. For maximum long-term preservation, storage at -20°C is recommended.
Is Cartalax third-party tested?
Yes. Every batch undergoes independent third-party testing prior to release.
Where can I access the COA for Cartalax?
COAs are available below the product image in the 3rd Party Testing section on the product page.
Is Cartalax FDA approved?
BioEdge Cartalax is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use in this form. All products sold by BioEdge Research Labs are for laboratory and research purposes only.
Do you ship Cartalax within the USA?
Yes. BioEdge Research Labs is a USA based supplier with same day domestic shipping on orders placed before 3pm Eastern. Free shipping on orders over $150.
Can I get bulk pricing on Cartalax?
Yes. Contact BioEdge Research Labs directly for institutional and bulk research pricing.
Published References
1. Mironova ES. “Peptides Affect Stem Cell Aging.” Lecture. Link
2. Storozhok NM, et al. “New approaches to stabilization of oxidation of lipid micellar systems with biologically active oligopeptides.” Russian Chemical Bulletin. 2014;63:2175-2183. Link
RESEARCH USE ONLY Disclaimer
RESEARCH USE ONLY. Cartalax is sold exclusively for in vitro laboratory and research purposes. This product is not intended for human or animal consumption, clinical use, or therapeutic application. It has not been evaluated by the Food and Drug Administration (FDA) for safety, efficacy, or any medical purpose. Purchase and use of this product confirms the buyer will use it only in qualified research settings, in compliance with all applicable federal, state, and local regulations. BioEdge Research Labs is a chemical supplier, not a compounding pharmacy or clinical facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. BioEdge Research Labs makes no claims regarding therapeutic, diagnostic, or clinical applications of this compound.
